Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 7Hot Flashes 6Breast Neoplasms 6Pain, Postoperative 4Prostatic Neoplasms 3Pain 3Vomiting 2Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Neuralgia 2Neoplasms 2Nausea 2Mucositis 2Anxiety Disorders 2Agnosia 2Acute Pain 2Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Rectal Neoplasms 1Psychotic Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Myalgia 1Lymphoma, Follicular 1Lung Neoplasms 1Laryngeal Diseases 1Ileus 1Glioblastoma 1

Interventions

Paclitaxel 7Oxaliplatin 6Vincristine 4Radiotherapy 4Leucovorin 4Carboplatin 4Amifostine 4Taxes 3Sodium Chloride 3Procarbazine 3Methotrexate 3Fluorouracil 3Cytarabine 3xaliproden 2glucarpidase 2Rituximab 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Prednisolone 2Magnesium Sulfate 2Duloxetine Hydrochloride 2Dexamethasone 2Cyclophosphamide 2Cisplatin 2Calcium Gluconate 2Acupuncture Therapy 2neurotropin 1motexafin gadolinium 1haloperidol decanoate 1glutamic acid diethyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neurotoxicity Syndromes × Gabapentin × Clear all
NCT00027963 2016-07-04

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
100 enrolled

Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡